Squamous Cell Carcinoma (SCC)
Gene or Region: DDB2
Reference Variant: C
Mutant Variant: T
Affected Breeds: Belgian and Haflinger
Research Confidence: Preliminary - Correlates in studies with humans
Explanation of Results: sccr/sccr = homozygous for Squamous Cell Carcinoma, 80% likely affected sccr/n = heterozygous for Squamous Cell Carcinoma, carrier n/n = no variant detected
General Information for Squamous Cell Carcinoma
Squamous Cell Carcinoma is the most common cause of eye cancer in horses. It is also responsible for a large percentage of tumors throughout other parts of the equine body. A recent correlation was discovered between Squamous Cell Carcinoma (SCC) and the DDB2 genetic region. A mutation identified in that region is hypothesized to affect the protein's active role of identifying and signaling DNA regions damaged by UV light for additional “repair” protein mechanisms which attempt to restore the region and thus, prevent tumor or cancer formation. This mutation for Squamous Cell Carcinoma is currently thought an autosomal recessive disorder, thus a horse must inherit two copies (scc/scc) to be at a greatly increased risk for cancer. Studies indicate that horses with two copies of SCC (sccr/sccr) are 80% likely to be affected by Squamous Cell Carcinoma. Horses with only one allele (sccr/n) are known as carriers due to their ability to produce affected offspring.
While early studies indicate a strong correlation between the SCC mutation of DDB2 and Haflinger and Belgian horses, current studies will continue to assess the occurrence in other breeds as well.
References
Lassaline M, Cranford TL, Latimer, CA, & Bellone R. (2015) Limbal squamous cell carcinoma in Haflinger horses. Vet Ophthalmol 18(5) 404-408.
Bellone RR, Liu J, Petersen JL, Mack M, Singer-Berk M, Drögemüller C, Malvick J, Wallner B, Brem G, Penedo MC, & Lassaline M. (2017) A Missense Mutation in Damage-specific DNA Binding Protein 2 Is a Genetic Risk Factor for Limbal Squamous Cell Carcinoma in Horses. Int. J. Cancer 141(2):342-353.
More Horse Health
Lavender Foal Syndrome
Lavender foal syndrome (LFS), also known as coat color dilution lethal, is a neurological dysfunction in newborn foals. Symptoms are apparent at birth and include seizures, severe hyper-extension of limbs, neck and back, stiff paddling leg movements, involuntary eye movement and inability to stand or sit upright. The coat usually has a dilute color that ranges in shade from silver to a pale lavender/pink. As there is no treatment, affected foals are humanely euthanized.
Lordosis
Lordosis (L1, L2, L3, L4), also known as "Swayback", is a curvature or dip in the spine that is often seen in older horses. However, in the American Saddlebred, this condition also affects younger horses. These animals do not appear to experience pain from their condition and are still able to be used under saddle.
Malignant Hyperthermia
Malignant hyperthermia (MH) is a muscle disorder in which anesthesia, stress, or extreme exercise trigger a hyperthermic state. Symptoms include high temperature, increased heart rate, high blood pressure, sweating, acidosis, and muscle rigidity. If symptoms are not immediately resolved, death is likely to occur.
Myosin-Heavy Chain Myopathy
Myosin-Heavy Chain Myopathy (MY; previously "IMM") is a genetic muscle disease found most commonly in stock-type horses that can result in two different presentations, Immune-Mediated Myositis (IMM) and Nonexertional Rhabdomyolysis “tying up,” which are both characterized by muscle damage or loss. Both presentations are associated with the same genetic variant. Horses with MYHM may exhibit one or both presentations at different times in their lives, although some horses carrying the variant might not display any symptoms at all.